Propofol and peanut allergy [13]

Anaesthesia

Volumn 62, Issue 11, 2007, Pages 1191-

  Gangineni, K ^a   Scase, A E ^a   Fearn, J ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL; PROPOVEN; UNCLASSIFIED DRUG;

ASTHMA; DRUG MARKETING; HUMAN; LETTER; PEANUT ALLERGY; PRACTICE GUIDELINE; TREATMENT CONTRAINDICATION;

ANESTHETICS, INTRAVENOUS; DRUG INFORMATION SERVICES; HUMANS; PEANUT HYPERSENSITIVITY; PROPOFOL;

EID: 35048895287     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05337.x     Document Type: Letter

References (3)

1. European Medicines Agency. Overview of the Comments Received on the 'Public Statement on the Use of Herbal Medicinal Products Containing Soya or Peanut Protein'. London: European Medicines Agency, 2006. http://www.emea. europa.eu/pdfs/human/hmpc/38140505en.pdf [accessed 14 March 2007].
2. European Medicines Agency. Public Statement on the Allergenic Potency of Herbal Medicinal Products Containing Soya or Peanut Protein. London:European Medicines Agency, 2006. http://www.emea.europa.eu/pdfs/human/hmpc/13813905en.pdf [accessed 4 December 2006).
3. Astra Zeneca. Summary of Product Characteristics. Macclesfield:Astra Zeneca, 2007. http://emc.medicines.org.uk [accessed 23 May 2007].